Addus HomeCare (ADUS) faces pressure after Q1 revenue misses Wall Street estimates

Addus HomeCare Corp. (ADUS) drew a negative market reaction after first-quarter revenue missed Wall Street expectations, despite year-over-year growth. Management attributed the shortfall to January winter storms that disrupted personal care visits and flat sales volumes. CEO Dirk Allison said some weather-affected visits could not be rescheduled, but operating trends returned to normal in February and March. The company cited improved hospice performance, benefits from recent acquisitions and rate increases in Illinois and Texas as margin supports. Investors are watching caregiver app adoption, utilization of authorized hours, integration of Indiana acquisitions and pending state rate reviews tied to Medicaid policy. Addus shares traded at $99.57 as of May 14, 2026, compared with $100.12 before the earnings release.